Kallistatin (SERPINA4)

Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and creation of a tiny C-terminal fragment of the inhibitor due to cleavage in the reactive site by tissue kallikrein.

.